Literature DB >> 34794178

COVID-19 Vaccination Rates in a Global HIV Cohort.

Evelynne S Fulda1, Kathleen V Fitch1, Edgar T Overton2, Markella V Zanni1, Judith A Aberg3, Judith S Currier4, Michael T Lu5, Carlos Malvestutto6, Carl J Fichtenbaum7, Esteban Martinez8, Triin Umbleja9, Pamela S Douglas10, Heather J Ribaudo9, Steven K Grinspoon1.   

Abstract

Little is known regarding coronavirus disease 2019 (COVID-19) vaccination rates in people with HIV (PWH), a vulnerable population with significant morbidity from COVID-19. We assessed COVID-19 vaccination rates among 6952 PWH in the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) compared to region- and country-specific vaccination data. The global probability of COVID-19 vaccination through end of July 2021 was 55% among REPRIEVE participants with rates varying substantially by Global Burden of Disease (GBD) superregion. Among PWH, factors associated with COVID-19 vaccination included residence in high-income regions, age, white race, male sex, body mass index, and higher cardiovascular risk. Clinical Trials Registration. NCT02344290.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; Global Burden of Disease region; human immunodeficiency virus; vaccination

Mesh：

Substances：

Year:  2022        PMID： 34794178      PMCID： PMC8844595          DOI： 10.1093/infdis/jiab575

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   7.759


  7 in total

1.  2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson; Harmon S Jordan; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

2.  Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE).

Authors:  Steven K Grinspoon; Kathleen V Fitch; Edgar Turner Overton; Carl J Fichtenbaum; Markella V Zanni; Judith A Aberg; Carlos Malvestutto; Michael T Lu; Judith S Currier; Craig A Sponseller; Myron Waclawiw; Beverly Alston-Smith; Katharine Cooper-Arnold; Karin L Klingman; Patrice Desvigne-Nickens; Udo Hoffmann; Heather J Ribaudo; Pamela S Douglas
Journal:  Am Heart J       Date:  2019-03-04       Impact factor: 4.749

3.  Strategies to Address COVID-19 Vaccine Hesitancy and Mitigate Health Disparities in Minority Populations.

Authors:  Kate W Strully; Teresa M Harrison; Theresa A Pardo; Jordan Carleo-Evangelist
Journal:  Front Public Health       Date:  2021-04-23

4.  Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.

Authors:  Carl J Fichtenbaum; Heather J Ribaudo; Jorge Leon-Cruz; Edgar T Overton; Markella V Zanni; Carlos D Malvestutto; Judith A Aberg; Emma M Kileel; Kathleen V Fitch; Marije Van Schalkwyk; Nagalingeswaran Kumarasamy; Esteban Martinez; Breno Riegel Santos; Yvetot Joseph; Janet Lo; Sue Siminski; Kathleen Melbourne; Craig A Sponseller; Patrice Desvigne-Nickens; Gerald S Bloomfield; Judith S Currier; Udo Hoffmann; Pamela S Douglas; Steven K Grinspoon
Journal:  J Infect Dis       Date:  2020-07-09       Impact factor: 7.759

5.  Hospitalized Patients With COVID-19 and Human Immunodeficiency Virus: A Case Series.

Authors:  Kate Childs; Frank A Post; Claire Norcross; Zoë Ottaway; Elizabeth Hamlyn; Killian Quinn; Thomas Juniper; Chris Taylor
Journal:  Clin Infect Dis       Date:  2020-11-05       Impact factor: 9.079

6.  HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform.

Authors:  Krishnan Bhaskaran; Christopher T Rentsch; Brian MacKenna; Anna Schultze; Amir Mehrkar; Chris J Bates; Rosalind M Eggo; Caroline E Morton; Sebastian C J Bacon; Peter Inglesby; Ian J Douglas; Alex J Walker; Helen I McDonald; Jonathan Cockburn; Elizabeth J Williamson; David Evans; Harriet J Forbes; Helen J Curtis; William J Hulme; John Parry; Frank Hester; Sam Harper; Stephen J W Evans; Liam Smeeth; Ben Goldacre
Journal:  Lancet HIV       Date:  2020-12-11       Impact factor: 12.767

7.  Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial.

Authors:  Pamela S Douglas; Triin Umbleja; Gerald S Bloomfield; Carl J Fichtenbaum; Markella V Zanni; Edgar T Overton; Kathleen V Fitch; Emma M Kileel; Judith A Aberg; Judith Currier; Craig A Sponseller; Kathleen Melbourne; Anchalee Avihingsanon; Flavio Bustorff; Vicente Estrada; Kiat Ruxrungtham; Maria Saumoy; Ann Marie Navar; Udo Hoffmann; Heather J Ribaudo; Steven Grinspoon
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 20.999
  7 in total
  1 in total

Review 1.  COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus.

Authors:  Niyati Jakharia; Aruna K Subramanian; Adrienne E Shapiro
Journal:  Infect Dis Clin North Am       Date:  2022-02-01       Impact factor: 5.905
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.